NAFLD and Alcohol-Associated Liver Disease Will Be Responsible for Almost All New Diagnoses of Cirrhosis in Canada by 2040
- PMID: 34174003
- DOI: 10.1002/hep.32032
NAFLD and Alcohol-Associated Liver Disease Will Be Responsible for Almost All New Diagnoses of Cirrhosis in Canada by 2040
Abstract
Background and aims: Mortality secondary to cirrhosis in North America is increasing. We describe the incidence of cirrhosis stratified by birth cohort and cirrhosis etiology and project disease burden to 2040.
Approach and results: This is a retrospective cohort study in Ontario, Canada, using population-based administrative health care data. Individuals with incident cirrhosis (2000-2017) were identified, and etiology was defined as HCV, HBV, NAFLD, alcohol-associated liver disease (ALD), or autoimmune liver disease/other using validated case definitions. Annual age/sex-adjusted cirrhosis incidence rate per 100,000 person-years was calculated with incidence projection to 2040 using age-period-cohort modeling along with average annual percent change (AAPC) in cirrhosis incidence stratified by birth cohort and etiology. In total, 159,549 incident cases of cirrhosis were identified. Incidence increased by 26% with an AAPC of 2%/year (95% CI, 1.6-2.4; P < 0.001). The largest increases were for HCV (AAPC, 4.1%/year; 95% CI, 2.6-5.7; P < 0.001) and NAFLD (AAPC, 3.3%/year; 95% CI, 2.6-4.1%; P < 0.001). ALD and HCV cirrhosis in those born >1980 increased by 11.6%/year (95% CI, 9.3-13.9; P < 0.001) and 9.5%/year (95% CI, 6.2-13.0; P < 0.001), respectively. However, by 2040, cirrhosis incidence is projected to continue to increase, driven mostly by NAFLD, especially in postmenopausal women, and ALD in individuals born >1980.
Conclusions: Cirrhosis incidence will continue to increase over the next two decades secondary to NAFLD with a worrisome rapid rise in ALD cirrhosis among young adults. Public education, policy, and intervention targeting NAFLD risk factors and alcohol use in young adults are urgently needed.
© 2021 American Association for the Study of Liver Diseases.
Similar articles
-
Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based study.Lancet Gastroenterol Hepatol. 2019 Mar;4(3):217-226. doi: 10.1016/S2468-1253(18)30339-X. Epub 2018 Dec 17. Lancet Gastroenterol Hepatol. 2019. PMID: 30573390
-
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27. Hepatology. 2020. PMID: 32043613
-
Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.Ann Hepatol. 2016 Mar-Apr;15(2):183-9. doi: 10.5604/16652681.1193707. Ann Hepatol. 2016. PMID: 26845595
-
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.Hepatology. 2018 Jan;67(1):123-133. doi: 10.1002/hep.29466. Epub 2017 Dec 1. Hepatology. 2018. PMID: 28802062 Free PMC article. Review.
-
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.Gastroenterology. 2016 Jun;150(8):1778-85. doi: 10.1053/j.gastro.2016.03.005. Epub 2016 Mar 12. Gastroenterology. 2016. PMID: 26980624 Review.
Cited by
-
A natural language processing algorithm accurately classifies steatotic liver disease pathology to estimate the risk of cirrhosis.Hepatol Commun. 2024 Mar 29;8(4):e0403. doi: 10.1097/HC9.0000000000000403. eCollection 2024 Apr 1. Hepatol Commun. 2024. PMID: 38551386 Free PMC article.
-
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions.World J Gastroenterol. 2022 Nov 7;28(41):5910-5930. doi: 10.3748/wjg.v28.i41.5910. World J Gastroenterol. 2022. PMID: 36405106 Free PMC article. Review.
-
Missed diagnosis of cirrhosis in the inpatient setting.J Hosp Med. 2022 Aug;17 Suppl 1(Suppl 1):S1-S7. doi: 10.1002/jhm.12918. J Hosp Med. 2022. PMID: 35972039 Free PMC article. Review.
-
Diagnosis of esophageal varices by liver stiffness and serum biomarkers in virus-related compensated advanced chronic liver disease.Can Liver J. 2023 Oct 30;6(3):332-346. doi: 10.3138/canlivj-2022-0047. eCollection 2023 Oct. Can Liver J. 2023. PMID: 38020192 Free PMC article.
-
Colorectal Cancer in Individuals with Cirrhosis: A Population-Based Study Assessing Practice Patterns, Outcomes, and Predictors of Survival.Curr Oncol. 2023 Oct 30;30(11):9530-9541. doi: 10.3390/curroncol30110690. Curr Oncol. 2023. PMID: 37999110 Free PMC article.
References
-
- Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one. In search of a pathophysiological classification of cirrhosis. Hepatology 2010;51:1445-1449. https://doi.org/10.1002/hep.23478.Now.
-
- Sepanlou SG, Safiri S, Bisignano C, Ikuta KS, Merat S, Saberifiroozi M, et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020;5:245-266. https://doi.org/10.1016/S2468-1253(19)30349-8.
-
- Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: Observational study. BMJ 2018;362:k2817. https://doi.org/10.1136/bmj.k2817.
-
- Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol 2020;18:2650-2666. https://doi.org/10.1016/j.cgh.2019.07.060.
-
- Statistics Canada. Table 13-10-0394-01. Leading causes of death, total population, by age group. https://doi.org/10.25318/1310039401-eng. Published November 26, 2020. Accessed May 30, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical